Uterine fibroids are the most common benign tumors in women of childbearing age and the second most common reason these women undergo surgery.
But as research advances and new approaches to care are implemented, will surgery become less necessary for women looking to eliminate symptoms?
That’s the question Erica Marsh, MD, chief of the division of reproductive endocrinology and infertility at the Center for Reproductive Medicine at U-M’s Von Voigtlander Women's Hospital, will debate during a keynote lecture at the annual The American College of Obstetricians and Gynecologists meeting at the end of April.
To read Dr. Marsh's thoughts on this and her answers to these questions, click here